InvestorsHub Logo
Followers 4
Posts 1049
Boards Moderated 0
Alias Born 08/01/2017

Re: zoran post# 49392

Tuesday, 02/13/2018 3:14:17 PM

Tuesday, February 13, 2018 3:14:17 PM

Post# of 97093
LOS ANGELES, CA / ACCESSWIRE / September 13, 2017 / Decision Diagnostics Corp. (OTC PINK: DECN) ("DECN") is a .... and now the new internationally launched GenSure!™ diabetes test strip. We are pleased to announce that our new GenSure!™ (the "Feather") diabetes test strip is available for sale in select international markets and will first be found primarily in Mexico, Central and South America, and the Far East with a target price at the international retail level at less than $0.15 per test strip, a veritable paradox.

Let's play a 1,000 questions ....

1 - Is it being sold under the name GenSure! or Feather?
2 - Is it being sold using a Spanish translation?
3 - Ever see what the packaging looks like?
4 - Does "is available for sale" mean it is actually being sold?
5 - "Will be fist found ...." - When? It has been 5 months since the above announcement?
6 - Is the "veritable paradox" the Hocus Pocus of this product? An illusion? A mis-direction?
7 - Far East? Has anyone from DECN pitched this opportunity to Kim Jong-um yet? He looks like he may be at risk for Type 2 Diabetes.

Are any of these questions unreasonable? Will any be answered in the Annual Report? Was the $17.5M deal supposed to back this launch?

This would all be FUNNY, if not so SAD!